 Sean O'Leary
Concepts (610)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 122 | 2026 | 1467 | 18.880 |
Why?
| | Vaccines | 38 | 2024 | 405 | 10.280 |
Why?
| | Influenza Vaccines | 44 | 2026 | 551 | 8.300 |
Why?
| | Papillomavirus Vaccines | 36 | 2025 | 317 | 8.180 |
Why?
| | Immunization | 29 | 2025 | 405 | 5.950 |
Why?
| | Health Knowledge, Attitudes, Practice | 41 | 2025 | 1395 | 5.540 |
Why?
| | Influenza, Human | 27 | 2026 | 625 | 5.340 |
Why?
| | Parents | 39 | 2025 | 1440 | 5.080 |
Why?
| | Papillomavirus Infections | 22 | 2025 | 363 | 4.860 |
Why?
| | Immunization Programs | 15 | 2025 | 221 | 4.640 |
Why?
| | Motivational Interviewing | 12 | 2025 | 118 | 4.620 |
Why?
| | Vaccination Refusal | 14 | 2022 | 70 | 4.440 |
Why?
| | Obstetrics | 14 | 2022 | 176 | 4.250 |
Why?
| | Gynecology | 13 | 2022 | 178 | 4.000 |
Why?
| | Patient Acceptance of Health Care | 26 | 2025 | 876 | 3.560 |
Why?
| | Attitude of Health Personnel | 30 | 2025 | 1175 | 3.470 |
Why?
| | Practice Patterns, Physicians' | 25 | 2024 | 1328 | 3.350 |
Why?
| | Advisory Committees | 20 | 2025 | 214 | 3.240 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 12 | 2022 | 96 | 3.110 |
Why?
| | Immunization Schedule | 22 | 2025 | 202 | 3.100 |
Why?
| | Meningococcal Vaccines | 13 | 2025 | 64 | 2.890 |
Why?
| | Vaccination Coverage | 10 | 2025 | 98 | 2.740 |
Why?
| | Pregnancy Complications, Infectious | 8 | 2023 | 406 | 2.700 |
Why?
| | Narration | 3 | 2026 | 68 | 2.570 |
Why?
| | Clergy | 4 | 2020 | 10 | 2.500 |
Why?
| | Humans | 254 | 2026 | 140898 | 2.420 |
Why?
| | Physicians, Primary Care | 12 | 2024 | 225 | 2.410 |
Why?
| | Colorado | 42 | 2026 | 4597 | 2.400 |
Why?
| | Child | 89 | 2025 | 22313 | 2.390 |
Why?
| | Health Personnel | 14 | 2024 | 724 | 2.250 |
Why?
| | Caregivers | 5 | 2026 | 940 | 2.180 |
Why?
| | Communication | 15 | 2025 | 948 | 2.140 |
Why?
| | Respiratory Syncytial Virus Vaccines | 8 | 2025 | 38 | 2.100 |
Why?
| | Hepatitis B | 4 | 2023 | 67 | 2.090 |
Why?
| | Infant | 55 | 2026 | 9790 | 1.930 |
Why?
| | Female | 155 | 2026 | 75540 | 1.930 |
Why?
| | Pediatrics | 16 | 2021 | 1097 | 1.880 |
Why?
| | Religion | 3 | 2020 | 68 | 1.830 |
Why?
| | Health Communication | 4 | 2021 | 48 | 1.820 |
Why?
| | Viral Vaccines | 4 | 2024 | 107 | 1.820 |
Why?
| | Pediatricians | 9 | 2024 | 131 | 1.810 |
Why?
| | Pregnancy | 47 | 2025 | 7035 | 1.790 |
Why?
| | Whooping Cough | 6 | 2022 | 55 | 1.710 |
Why?
| | United States | 60 | 2025 | 15195 | 1.670 |
Why?
| | Adult | 89 | 2026 | 39134 | 1.660 |
Why?
| | Attitude to Health | 9 | 2020 | 451 | 1.650 |
Why?
| | Neurosurgical Procedures | 5 | 2025 | 197 | 1.610 |
Why?
| | Reminder Systems | 5 | 2026 | 174 | 1.580 |
Why?
| | Adolescent | 68 | 2025 | 22027 | 1.580 |
Why?
| | Male | 109 | 2026 | 69893 | 1.420 |
Why?
| | Social Media | 4 | 2021 | 159 | 1.290 |
Why?
| | Treatment Refusal | 5 | 2020 | 96 | 1.270 |
Why?
| | Primary Health Care | 14 | 2024 | 1756 | 1.240 |
Why?
| | Child, Preschool | 36 | 2026 | 11462 | 1.230 |
Why?
| | Health Promotion | 5 | 2020 | 748 | 1.140 |
Why?
| | Mass Screening | 3 | 2025 | 1300 | 1.120 |
Why?
| | Physicians, Family | 10 | 2021 | 192 | 1.110 |
Why?
| | Surveys and Questionnaires | 33 | 2024 | 5931 | 1.110 |
Why?
| | Pseudotumor Cerebri | 2 | 2025 | 30 | 1.110 |
Why?
| | Adolescent Health Services | 4 | 2015 | 76 | 1.100 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 6 | 2024 | 143 | 1.100 |
Why?
| | Middle Aged | 56 | 2026 | 34487 | 1.030 |
Why?
| | Safety-net Providers | 3 | 2025 | 124 | 1.010 |
Why?
| | Qualitative Research | 12 | 2025 | 1525 | 1.000 |
Why?
| | Emergency Service, Hospital | 4 | 2025 | 2190 | 1.000 |
Why?
| | Measles | 4 | 2022 | 48 | 0.980 |
Why?
| | Prenatal Care | 2 | 2020 | 301 | 0.980 |
Why?
| | Practice Guidelines as Topic | 12 | 2025 | 1536 | 0.950 |
Why?
| | Spinal Cord | 2 | 2025 | 375 | 0.950 |
Why?
| | Physicians | 11 | 2022 | 928 | 0.940 |
Why?
| | Infectious Disease Transmission, Vertical | 4 | 2023 | 186 | 0.930 |
Why?
| | Diphtheria | 4 | 2022 | 22 | 0.930 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2025 | 25 | 0.930 |
Why?
| | Tetanus | 4 | 2022 | 27 | 0.930 |
Why?
| | Measles-Mumps-Rubella Vaccine | 3 | 2022 | 47 | 0.930 |
Why?
| | Patient Outcome Assessment | 2 | 2019 | 131 | 0.920 |
Why?
| | Stereotaxic Techniques | 1 | 2025 | 40 | 0.920 |
Why?
| | Rural Health Services | 2 | 2024 | 140 | 0.910 |
Why?
| | Knee Prosthesis | 1 | 2025 | 26 | 0.910 |
Why?
| | Policy | 3 | 2020 | 145 | 0.890 |
Why?
| | Bone Cysts, Aneurysmal | 1 | 2024 | 2 | 0.880 |
Why?
| | Health Care Surveys | 12 | 2021 | 562 | 0.880 |
Why?
| | Prosthesis Failure | 1 | 2025 | 125 | 0.870 |
Why?
| | Pandemics | 6 | 2024 | 1643 | 0.860 |
Why?
| | Preventive Health Services | 3 | 2025 | 154 | 0.860 |
Why?
| | Orbital Diseases | 1 | 2024 | 32 | 0.860 |
Why?
| | Anterior Cruciate Ligament Injuries | 5 | 2024 | 162 | 0.840 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2024 | 67 | 0.840 |
Why?
| | Community Participation | 2 | 2025 | 132 | 0.830 |
Why?
| | Osteomyelitis | 2 | 2024 | 143 | 0.820 |
Why?
| | Laser Therapy | 1 | 2025 | 128 | 0.810 |
Why?
| | Schools | 3 | 2025 | 451 | 0.780 |
Why?
| | Trust | 4 | 2024 | 144 | 0.780 |
Why?
| | Central Nervous System Neoplasms | 1 | 2025 | 168 | 0.780 |
Why?
| | Arthroplasty, Replacement, Knee | 2 | 2025 | 372 | 0.780 |
Why?
| | Ambulatory Care | 4 | 2020 | 584 | 0.770 |
Why?
| | Religion and Medicine | 2 | 2019 | 32 | 0.760 |
Why?
| | Physician-Patient Relations | 5 | 2020 | 580 | 0.760 |
Why?
| | Respiratory Syncytial Virus Infections | 5 | 2025 | 131 | 0.760 |
Why?
| | Health Equity | 1 | 2024 | 102 | 0.760 |
Why?
| | Developing Countries | 1 | 2024 | 307 | 0.760 |
Why?
| | Prefrontal Cortex | 1 | 2025 | 316 | 0.760 |
Why?
| | Lipid Metabolism | 1 | 2025 | 525 | 0.740 |
Why?
| | Hepatitis B Vaccines | 4 | 2023 | 43 | 0.720 |
Why?
| | Health Services Research | 4 | 2019 | 402 | 0.720 |
Why?
| | Young Adult | 27 | 2025 | 13646 | 0.710 |
Why?
| | Infant, Newborn | 17 | 2025 | 6257 | 0.710 |
Why?
| | Refusal to Treat | 2 | 2020 | 16 | 0.710 |
Why?
| | Brain Neoplasms | 3 | 2025 | 1275 | 0.710 |
Why?
| | Urban Population | 4 | 2024 | 481 | 0.700 |
Why?
| | Global Health | 1 | 2024 | 381 | 0.700 |
Why?
| | Cochlear Implantation | 1 | 2022 | 76 | 0.700 |
Why?
| | Rural Population | 6 | 2024 | 605 | 0.690 |
Why?
| | Cochlear Implants | 1 | 2022 | 91 | 0.690 |
Why?
| | Herpes Zoster Vaccine | 6 | 2022 | 160 | 0.690 |
Why?
| | Arthritis, Infectious | 1 | 2022 | 73 | 0.690 |
Why?
| | Burns | 1 | 2025 | 349 | 0.680 |
Why?
| | Lipids | 1 | 2025 | 689 | 0.680 |
Why?
| | Suicide | 2 | 2025 | 669 | 0.680 |
Why?
| | Private Practice | 1 | 2020 | 20 | 0.680 |
Why?
| | Standing Orders | 2 | 2020 | 11 | 0.670 |
Why?
| | Pneumococcal Vaccines | 6 | 2021 | 138 | 0.670 |
Why?
| | Streptococcal Vaccines | 2 | 2025 | 7 | 0.670 |
Why?
| | Professional-Patient Relations | 3 | 2018 | 151 | 0.660 |
Why?
| | Myocarditis | 1 | 2021 | 100 | 0.640 |
Why?
| | Anti-Vaccination Movement | 1 | 2019 | 4 | 0.640 |
Why?
| | Stakeholder Participation | 1 | 2020 | 81 | 0.640 |
Why?
| | Registries | 5 | 2025 | 2143 | 0.630 |
Why?
| | Longevity | 1 | 2021 | 175 | 0.620 |
Why?
| | Freedom | 1 | 2019 | 14 | 0.620 |
Why?
| | Text Messaging | 3 | 2019 | 179 | 0.620 |
Why?
| | Health Care Costs | 3 | 2020 | 418 | 0.620 |
Why?
| | Cross-Sectional Studies | 12 | 2024 | 5645 | 0.610 |
Why?
| | Public Health | 4 | 2024 | 554 | 0.600 |
Why?
| | Hearing Loss | 1 | 2022 | 234 | 0.590 |
Why?
| | Healthcare Disparities | 3 | 2024 | 671 | 0.590 |
Why?
| | Chickenpox Vaccine | 3 | 2017 | 74 | 0.590 |
Why?
| | Brain Injuries, Traumatic | 1 | 2024 | 400 | 0.580 |
Why?
| | Disease Outbreaks | 3 | 2022 | 418 | 0.580 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2020 | 151 | 0.570 |
Why?
| | Streptococcal Infections | 2 | 2025 | 151 | 0.570 |
Why?
| | Information Seeking Behavior | 1 | 2018 | 37 | 0.560 |
Why?
| | Rotavirus Infections | 2 | 2021 | 39 | 0.560 |
Why?
| | Rotavirus Vaccines | 2 | 2021 | 42 | 0.560 |
Why?
| | Down Syndrome | 2 | 2021 | 505 | 0.550 |
Why?
| | Documentation | 2 | 2019 | 193 | 0.540 |
Why?
| | Patient Preference | 2 | 2017 | 203 | 0.540 |
Why?
| | Mothers | 5 | 2022 | 777 | 0.540 |
Why?
| | Retrospective Studies | 28 | 2025 | 16315 | 0.540 |
Why?
| | Hepatitis A Vaccines | 4 | 2019 | 15 | 0.530 |
Why?
| | Infertility | 3 | 2023 | 55 | 0.530 |
Why?
| | Neuroendoscopy | 3 | 2025 | 24 | 0.520 |
Why?
| | Cues | 1 | 2019 | 323 | 0.510 |
Why?
| | Interviews as Topic | 6 | 2025 | 841 | 0.510 |
Why?
| | Mass Media | 1 | 2016 | 40 | 0.500 |
Why?
| | Evidence-Based Medicine | 5 | 2024 | 712 | 0.500 |
Why?
| | Physician's Role | 2 | 2019 | 217 | 0.500 |
Why?
| | Mumps | 3 | 2022 | 24 | 0.490 |
Why?
| | Health Education | 2 | 2018 | 360 | 0.480 |
Why?
| | Health Policy | 2 | 2025 | 380 | 0.470 |
Why?
| | Delivery of Health Care | 3 | 2023 | 949 | 0.470 |
Why?
| | Arachnoid Cysts | 2 | 2025 | 9 | 0.470 |
Why?
| | School Health Services | 3 | 2015 | 233 | 0.470 |
Why?
| | Aged | 27 | 2025 | 24666 | 0.470 |
Why?
| | Vaccines, Combined | 4 | 2023 | 49 | 0.460 |
Why?
| | Cost-Benefit Analysis | 4 | 2024 | 609 | 0.460 |
Why?
| | Computers, Handheld | 1 | 2015 | 26 | 0.450 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2018 | 267 | 0.440 |
Why?
| | Dengue Vaccines | 3 | 2019 | 11 | 0.430 |
Why?
| | Anthrax Vaccines | 3 | 2018 | 7 | 0.430 |
Why?
| | Treatment Outcome | 14 | 2025 | 11125 | 0.430 |
Why?
| | Hepatitis B Surface Antigens | 2 | 2023 | 21 | 0.410 |
Why?
| | Recovery of Function | 2 | 2020 | 680 | 0.410 |
Why?
| | United Kingdom | 6 | 2025 | 319 | 0.400 |
Why?
| | Internet | 5 | 2019 | 682 | 0.390 |
Why?
| | Aged, 80 and over | 10 | 2025 | 7899 | 0.390 |
Why?
| | Patient-Centered Care | 2 | 2015 | 536 | 0.380 |
Why?
| | Seizures, Febrile | 1 | 2012 | 22 | 0.380 |
Why?
| | Washington | 2 | 2025 | 159 | 0.380 |
Why?
| | Meningococcal Infections | 3 | 2018 | 30 | 0.370 |
Why?
| | Nurseries, Hospital | 1 | 2012 | 5 | 0.370 |
Why?
| | Herpes Zoster | 3 | 2022 | 319 | 0.370 |
Why?
| | Infertility, Female | 3 | 2021 | 107 | 0.370 |
Why?
| | Anti-Bacterial Agents | 5 | 2024 | 1856 | 0.370 |
Why?
| | Safety | 2 | 2020 | 356 | 0.370 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 15 | 0.360 |
Why?
| | Georgia | 6 | 2021 | 85 | 0.360 |
Why?
| | Anti-Mullerian Hormone | 2 | 2022 | 58 | 0.360 |
Why?
| | Community-Based Participatory Research | 2 | 2025 | 162 | 0.350 |
Why?
| | Age Factors | 6 | 2021 | 3278 | 0.350 |
Why?
| | Family Practice | 7 | 2017 | 440 | 0.350 |
Why?
| | Skin Diseases, Bacterial | 3 | 2016 | 21 | 0.340 |
Why?
| | Rotator Cuff | 3 | 2009 | 47 | 0.340 |
Why?
| | Mumps Vaccine | 3 | 2021 | 12 | 0.330 |
Why?
| | Pertussis Vaccine | 3 | 2022 | 24 | 0.330 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2022 | 1598 | 0.320 |
Why?
| | Attitude | 3 | 2021 | 257 | 0.310 |
Why?
| | Tenodesis | 1 | 2009 | 21 | 0.310 |
Why?
| | Propensity Score | 3 | 2025 | 332 | 0.300 |
Why?
| | Australia | 4 | 2023 | 286 | 0.300 |
Why?
| | Japanese Encephalitis Vaccines | 2 | 2018 | 2 | 0.300 |
Why?
| | Breast Neoplasms | 1 | 2021 | 2235 | 0.290 |
Why?
| | Tendon Injuries | 1 | 2009 | 67 | 0.290 |
Why?
| | Vaccines, Contraceptive | 1 | 2008 | 1 | 0.290 |
Why?
| | Hepatitis B virus | 2 | 2023 | 33 | 0.290 |
Why?
| | Ovulation | 1 | 2008 | 40 | 0.290 |
Why?
| | Egg Proteins | 1 | 2008 | 21 | 0.290 |
Why?
| | Guideline Adherence | 2 | 2013 | 553 | 0.280 |
Why?
| | Ovarian Follicle | 1 | 2008 | 72 | 0.280 |
Why?
| | Skull Base | 2 | 2025 | 55 | 0.270 |
Why?
| | Cytomegalovirus | 1 | 2008 | 163 | 0.270 |
Why?
| | Cerebral Ventricles | 2 | 2025 | 54 | 0.270 |
Why?
| | Child Health | 2 | 2019 | 153 | 0.260 |
Why?
| | Societies, Medical | 4 | 2019 | 852 | 0.260 |
Why?
| | Professional-Family Relations | 3 | 2018 | 152 | 0.260 |
Why?
| | Mobile Applications | 2 | 2020 | 176 | 0.260 |
Why?
| | Maternal Health Services | 2 | 2019 | 103 | 0.260 |
Why?
| | Postoperative Complications | 4 | 2025 | 2813 | 0.260 |
Why?
| | Vaccines, Synthetic | 3 | 2022 | 138 | 0.250 |
Why?
| | Respiratory Syncytial Viruses | 2 | 2023 | 58 | 0.250 |
Why?
| | Databases, Factual | 4 | 2025 | 1441 | 0.250 |
Why?
| | Logistic Models | 3 | 2021 | 2088 | 0.250 |
Why?
| | Data Collection | 3 | 2014 | 651 | 0.240 |
Why?
| | Receptors, Cell Surface | 1 | 2008 | 398 | 0.240 |
Why?
| | Hematoma, Subdural, Chronic | 1 | 2025 | 4 | 0.240 |
Why?
| | Cohort Studies | 6 | 2025 | 5789 | 0.240 |
Why?
| | Cranial Fossa, Middle | 1 | 2025 | 17 | 0.240 |
Why?
| | Membrane Glycoproteins | 1 | 2008 | 501 | 0.240 |
Why?
| | Arthroplasty | 2 | 2003 | 53 | 0.230 |
Why?
| | Early Ambulation | 1 | 2025 | 25 | 0.230 |
Why?
| | Polyethylene | 1 | 2025 | 17 | 0.230 |
Why?
| | Child Care | 1 | 2025 | 33 | 0.230 |
Why?
| | Acetazolamide | 1 | 2025 | 26 | 0.230 |
Why?
| | Pneumocephalus | 1 | 2025 | 5 | 0.230 |
Why?
| | Blood Coagulation Factors | 1 | 2025 | 60 | 0.230 |
Why?
| | Blood Transfusion | 2 | 2025 | 393 | 0.230 |
Why?
| | Shoulder Joint | 2 | 2008 | 177 | 0.230 |
Why?
| | Privacy | 1 | 2025 | 39 | 0.230 |
Why?
| | Cerebrospinal Fluid Rhinorrhea | 1 | 2024 | 10 | 0.230 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2025 | 70 | 0.230 |
Why?
| | Medically Underserved Area | 1 | 2025 | 99 | 0.230 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2025 | 52 | 0.220 |
Why?
| | Craniosynostoses | 1 | 2025 | 58 | 0.220 |
Why?
| | Antibodies, Bacterial | 1 | 2025 | 145 | 0.220 |
Why?
| | Cerebral Hemorrhage | 1 | 2025 | 116 | 0.220 |
Why?
| | Haemophilus Vaccines | 1 | 2024 | 30 | 0.220 |
Why?
| | Syndrome | 1 | 2025 | 377 | 0.220 |
Why?
| | Streptococcus agalactiae | 1 | 2025 | 91 | 0.220 |
Why?
| | Community Health Centers | 1 | 2024 | 63 | 0.220 |
Why?
| | Intracranial Hemorrhages | 1 | 2025 | 94 | 0.220 |
Why?
| | Time Factors | 4 | 2020 | 6944 | 0.210 |
Why?
| | Pregnancy Rate | 5 | 2023 | 67 | 0.210 |
Why?
| | California | 3 | 2025 | 455 | 0.210 |
Why?
| | Acne Vulgaris | 1 | 2024 | 26 | 0.210 |
Why?
| | Astrocytoma | 1 | 2025 | 130 | 0.210 |
Why?
| | Disease Management | 2 | 2025 | 628 | 0.210 |
Why?
| | Stroke | 2 | 2025 | 1158 | 0.210 |
Why?
| | Patellar Ligament | 1 | 2024 | 25 | 0.210 |
Why?
| | Absenteeism | 1 | 2024 | 52 | 0.210 |
Why?
| | Home Health Aides | 1 | 2023 | 6 | 0.210 |
Why?
| | Seasons | 2 | 2020 | 542 | 0.210 |
Why?
| | Orbit | 1 | 2024 | 70 | 0.210 |
Why?
| | Patient Education as Topic | 2 | 2019 | 772 | 0.210 |
Why?
| | Prosthesis Design | 2 | 2025 | 338 | 0.210 |
Why?
| | Tibia | 1 | 2025 | 181 | 0.210 |
Why?
| | Musculoskeletal Diseases | 1 | 2025 | 84 | 0.210 |
Why?
| | Bacterial Vaccines | 1 | 2024 | 63 | 0.210 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2024 | 89 | 0.200 |
Why?
| | Blood Coagulation Tests | 1 | 2023 | 73 | 0.200 |
Why?
| | Toll-Like Receptor 4 | 1 | 2025 | 276 | 0.200 |
Why?
| | Prospective Studies | 5 | 2022 | 7749 | 0.200 |
Why?
| | Reoperation | 2 | 2025 | 590 | 0.200 |
Why?
| | Perioperative Care | 1 | 2025 | 226 | 0.200 |
Why?
| | Drug Resistant Epilepsy | 1 | 2024 | 105 | 0.200 |
Why?
| | Pituitary Neoplasms | 1 | 2025 | 194 | 0.200 |
Why?
| | Decision Making | 3 | 2020 | 950 | 0.200 |
Why?
| | Audiometry, Evoked Response | 1 | 2022 | 12 | 0.190 |
Why?
| | Silicone Elastomers | 1 | 2002 | 7 | 0.190 |
Why?
| | Oxytocics | 1 | 2022 | 15 | 0.190 |
Why?
| | Biological Transport | 1 | 2024 | 409 | 0.190 |
Why?
| | Joint Prosthesis | 1 | 2002 | 21 | 0.190 |
Why?
| | Hospitalization | 8 | 2024 | 2261 | 0.190 |
Why?
| | Gout | 1 | 2003 | 38 | 0.190 |
Why?
| | Suicidal Ideation | 2 | 2025 | 539 | 0.190 |
Why?
| | Hospitals | 3 | 2023 | 694 | 0.190 |
Why?
| | Prostaglandins | 1 | 2022 | 101 | 0.190 |
Why?
| | Thumb | 1 | 2002 | 34 | 0.190 |
Why?
| | Ovulation Induction | 2 | 2022 | 56 | 0.190 |
Why?
| | Sperm Injections, Intracytoplasmic | 1 | 2022 | 8 | 0.190 |
Why?
| | Diagnostic Imaging | 1 | 2025 | 326 | 0.190 |
Why?
| | Risk Factors | 9 | 2025 | 10430 | 0.190 |
Why?
| | Pilot Projects | 2 | 2026 | 1815 | 0.190 |
Why?
| | Algorithms | 3 | 2025 | 1763 | 0.180 |
Why?
| | Cochlea | 1 | 2022 | 71 | 0.180 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2025 | 908 | 0.180 |
Why?
| | Orthopedic Procedures | 2 | 2023 | 229 | 0.180 |
Why?
| | Rubella | 1 | 2022 | 23 | 0.180 |
Why?
| | Case-Control Studies | 3 | 2025 | 3578 | 0.180 |
Why?
| | Infant Health | 1 | 2022 | 24 | 0.180 |
Why?
| | Neisseria meningitidis, Serogroup B | 2 | 2018 | 18 | 0.180 |
Why?
| | NF-kappa B | 1 | 2025 | 690 | 0.180 |
Why?
| | Uterine Diseases | 1 | 2021 | 17 | 0.180 |
Why?
| | Fertilization in Vitro | 4 | 2023 | 85 | 0.180 |
Why?
| | Intention | 2 | 2020 | 179 | 0.180 |
Why?
| | Intrauterine Devices | 1 | 2021 | 29 | 0.180 |
Why?
| | Russia | 1 | 2021 | 13 | 0.170 |
Why?
| | Knee Injuries | 1 | 2022 | 102 | 0.170 |
Why?
| | Radiosurgery | 1 | 2025 | 389 | 0.170 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2023 | 187 | 0.170 |
Why?
| | Automobile Driving | 1 | 2023 | 152 | 0.170 |
Why?
| | Live Birth | 4 | 2023 | 68 | 0.170 |
Why?
| | Yellow Fever Vaccine | 2 | 2017 | 7 | 0.170 |
Why?
| | Risk | 2 | 2015 | 903 | 0.170 |
Why?
| | Germany | 1 | 2021 | 131 | 0.170 |
Why?
| | Regression Analysis | 2 | 2020 | 1015 | 0.170 |
Why?
| | Complementary Therapies | 1 | 2022 | 90 | 0.170 |
Why?
| | Demography | 2 | 2024 | 295 | 0.170 |
Why?
| | Hospital Rapid Response Team | 1 | 2021 | 21 | 0.170 |
Why?
| | General Practitioners | 1 | 2021 | 26 | 0.170 |
Why?
| | Cluster Analysis | 2 | 2022 | 516 | 0.170 |
Why?
| | Age Distribution | 1 | 2021 | 397 | 0.160 |
Why?
| | Triage | 1 | 2023 | 246 | 0.160 |
Why?
| | Antiviral Agents | 2 | 2023 | 746 | 0.160 |
Why?
| | Ventriculostomy | 1 | 2000 | 23 | 0.160 |
Why?
| | Staphylococcal Infections | 1 | 2025 | 391 | 0.160 |
Why?
| | Mental Health Services | 1 | 2025 | 445 | 0.160 |
Why?
| | Internal Medicine | 2 | 2014 | 273 | 0.160 |
Why?
| | Anterior Cruciate Ligament | 2 | 2024 | 81 | 0.160 |
Why?
| | Cytokines | 2 | 2025 | 2092 | 0.160 |
Why?
| | Measles Vaccine | 1 | 2019 | 21 | 0.160 |
Why?
| | Rats, Sprague-Dawley | 1 | 2025 | 2522 | 0.160 |
Why?
| | Hyperglycemia | 1 | 2024 | 363 | 0.160 |
Why?
| | Osteoarthritis | 1 | 2002 | 203 | 0.160 |
Why?
| | Drug Storage | 1 | 2020 | 53 | 0.160 |
Why?
| | Fever | 1 | 2021 | 308 | 0.160 |
Why?
| | Norovirus | 1 | 2020 | 26 | 0.160 |
Why?
| | Clinical Competence | 2 | 2018 | 1196 | 0.160 |
Why?
| | Eligibility Determination | 1 | 2020 | 68 | 0.160 |
Why?
| | Thrombosis | 1 | 2024 | 398 | 0.160 |
Why?
| | Government Regulation | 1 | 2019 | 38 | 0.150 |
Why?
| | State Government | 1 | 2019 | 45 | 0.150 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2020 | 96 | 0.150 |
Why?
| | Reimbursement Mechanisms | 1 | 2020 | 82 | 0.150 |
Why?
| | Pennsylvania | 1 | 2019 | 134 | 0.150 |
Why?
| | von Willebrand Factor | 1 | 2019 | 84 | 0.150 |
Why?
| | Medicaid | 2 | 2021 | 446 | 0.150 |
Why?
| | Gastroenteritis | 1 | 2020 | 68 | 0.150 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2017 | 97 | 0.150 |
Why?
| | Motivation | 1 | 2024 | 599 | 0.150 |
Why?
| | Europe | 1 | 2020 | 406 | 0.150 |
Why?
| | Therapeutic Uses | 1 | 2018 | 1 | 0.150 |
Why?
| | Morbidity | 1 | 2020 | 320 | 0.150 |
Why?
| | Insemination, Artificial | 1 | 2018 | 11 | 0.150 |
Why?
| | Clomiphene | 1 | 2018 | 15 | 0.150 |
Why?
| | Thromboembolism | 1 | 2019 | 118 | 0.150 |
Why?
| | Fertility Agents, Female | 1 | 2018 | 21 | 0.140 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 413 | 0.140 |
Why?
| | Urban Health Services | 1 | 2018 | 68 | 0.140 |
Why?
| | Machine Learning | 2 | 2025 | 554 | 0.140 |
Why?
| | Hearing Loss, Sudden | 1 | 2018 | 7 | 0.140 |
Why?
| | Education, Continuing | 1 | 2018 | 41 | 0.140 |
Why?
| | Melanoma | 1 | 2025 | 792 | 0.140 |
Why?
| | Nuclear Family | 1 | 2018 | 57 | 0.140 |
Why?
| | Placentation | 1 | 2017 | 46 | 0.140 |
Why?
| | Smoking | 1 | 2025 | 1573 | 0.140 |
Why?
| | Skin Neoplasms | 1 | 2025 | 853 | 0.130 |
Why?
| | Ambulatory Care Facilities | 2 | 2019 | 246 | 0.130 |
Why?
| | Evidence-Based Practice | 2 | 2020 | 229 | 0.130 |
Why?
| | Guatemala | 4 | 2020 | 346 | 0.130 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2018 | 68 | 0.130 |
Why?
| | Trace Elements | 1 | 2017 | 51 | 0.130 |
Why?
| | Cervical Plexus | 1 | 1997 | 2 | 0.130 |
Why?
| | Altitude | 1 | 2021 | 473 | 0.130 |
Why?
| | Quality Improvement | 3 | 2020 | 1234 | 0.130 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2017 | 80 | 0.130 |
Why?
| | Rats | 1 | 2025 | 5594 | 0.130 |
Why?
| | Spinal Nerve Roots | 1 | 1997 | 29 | 0.130 |
Why?
| | Body Mass Index | 1 | 2025 | 2374 | 0.130 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1496 | 0.130 |
Why?
| | Morphogenesis | 1 | 2017 | 171 | 0.130 |
Why?
| | Pneumococcal Infections | 1 | 2018 | 108 | 0.130 |
Why?
| | Administrative Personnel | 1 | 2016 | 30 | 0.130 |
Why?
| | Travel | 1 | 2017 | 136 | 0.130 |
Why?
| | Telemedicine | 1 | 2025 | 886 | 0.130 |
Why?
| | Physician Executives | 1 | 2016 | 30 | 0.120 |
Why?
| | Allied Health Personnel | 1 | 2016 | 53 | 0.120 |
Why?
| | Vaccines, Conjugate | 2 | 2018 | 63 | 0.120 |
Why?
| | Cost of Illness | 2 | 2018 | 310 | 0.120 |
Why?
| | Hemorrhage | 1 | 2021 | 760 | 0.120 |
Why?
| | Public Health Practice | 1 | 2016 | 67 | 0.120 |
Why?
| | Diphtheria Toxoid | 1 | 2015 | 13 | 0.120 |
Why?
| | Adaptation, Psychological | 2 | 2020 | 678 | 0.120 |
Why?
| | Behavior Therapy | 1 | 2019 | 282 | 0.120 |
Why?
| | Blood Platelets | 1 | 2019 | 436 | 0.120 |
Why?
| | Brain Ischemia | 1 | 2019 | 349 | 0.120 |
Why?
| | Tetanus Toxoid | 1 | 2015 | 37 | 0.120 |
Why?
| | Curriculum | 1 | 2023 | 1029 | 0.120 |
Why?
| | Incidence | 2 | 2020 | 2782 | 0.120 |
Why?
| | Herpesvirus 3, Human | 1 | 2019 | 336 | 0.120 |
Why?
| | Equipment and Supplies | 1 | 2015 | 34 | 0.120 |
Why?
| | Minority Groups | 1 | 2018 | 277 | 0.120 |
Why?
| | Patient Participation | 1 | 2019 | 424 | 0.120 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 76 | 0.120 |
Why?
| | Postpartum Period | 1 | 2018 | 343 | 0.120 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2018 | 179 | 0.120 |
Why?
| | Information Dissemination | 1 | 2017 | 209 | 0.120 |
Why?
| | Health Services Accessibility | 2 | 2024 | 1020 | 0.120 |
Why?
| | Focus Groups | 5 | 2018 | 567 | 0.120 |
Why?
| | Cooperative Behavior | 3 | 2014 | 455 | 0.110 |
Why?
| | Zika Virus Infection | 1 | 2017 | 165 | 0.110 |
Why?
| | Leadership | 1 | 2019 | 391 | 0.110 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4407 | 0.110 |
Why?
| | Africa | 2 | 2025 | 115 | 0.110 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2017 | 237 | 0.110 |
Why?
| | Neck Pain | 1 | 2014 | 27 | 0.110 |
Why?
| | Occupational Health Services | 1 | 2014 | 35 | 0.110 |
Why?
| | Zinc | 1 | 2017 | 299 | 0.110 |
Why?
| | Lung Diseases | 1 | 2021 | 793 | 0.110 |
Why?
| | Acute Disease | 4 | 2025 | 1010 | 0.110 |
Why?
| | Prevalence | 1 | 2021 | 2780 | 0.110 |
Why?
| | Nurses | 1 | 2016 | 182 | 0.100 |
Why?
| | Poverty | 1 | 2018 | 527 | 0.100 |
Why?
| | Animals | 5 | 2025 | 37579 | 0.100 |
Why?
| | Public Health Administration | 1 | 2014 | 74 | 0.100 |
Why?
| | State Medicine | 2 | 2024 | 25 | 0.100 |
Why?
| | Sexual Behavior | 1 | 2018 | 493 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2025 | 2082 | 0.100 |
Why?
| | Circovirus | 1 | 2013 | 6 | 0.100 |
Why?
| | Social Behavior | 1 | 2015 | 287 | 0.100 |
Why?
| | Intussusception | 1 | 2013 | 26 | 0.100 |
Why?
| | Drug Contamination | 1 | 2013 | 51 | 0.100 |
Why?
| | Clinical Decision-Making | 3 | 2021 | 339 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2018 | 537 | 0.100 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2013 | 68 | 0.100 |
Why?
| | Serogroup | 2 | 2025 | 45 | 0.090 |
Why?
| | Hemodynamics | 1 | 2017 | 1100 | 0.090 |
Why?
| | Fertilization | 2 | 2023 | 44 | 0.090 |
Why?
| | Workplace | 1 | 2014 | 264 | 0.090 |
Why?
| | Brain | 1 | 2024 | 2852 | 0.090 |
Why?
| | Obesity | 1 | 2025 | 3000 | 0.090 |
Why?
| | Parent-Child Relations | 1 | 2015 | 285 | 0.090 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5194 | 0.090 |
Why?
| | Neisseria meningitidis | 1 | 2011 | 25 | 0.090 |
Why?
| | Professional Practice Location | 1 | 2011 | 28 | 0.090 |
Why?
| | Community-Institutional Relations | 1 | 2012 | 102 | 0.090 |
Why?
| | Patient Compliance | 1 | 2016 | 607 | 0.090 |
Why?
| | Outpatients | 1 | 2015 | 418 | 0.090 |
Why?
| | Perinatal Care | 1 | 2012 | 60 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2019 | 1125 | 0.090 |
Why?
| | Placenta | 1 | 2017 | 764 | 0.080 |
Why?
| | Sensitivity and Specificity | 3 | 2025 | 1968 | 0.080 |
Why?
| | Birth Rate | 2 | 2022 | 29 | 0.080 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2010 | 47 | 0.080 |
Why?
| | Quality of Life | 3 | 2024 | 3005 | 0.080 |
Why?
| | Swine | 1 | 2013 | 809 | 0.080 |
Why?
| | Pain Measurement | 1 | 2012 | 552 | 0.080 |
Why?
| | Hospices | 1 | 2011 | 88 | 0.080 |
Why?
| | Sports | 1 | 2012 | 219 | 0.080 |
Why?
| | Cognition | 1 | 2018 | 1220 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2524 | 0.080 |
Why?
| | Rotator Cuff Injuries | 1 | 2009 | 62 | 0.070 |
Why?
| | Activities of Daily Living | 1 | 2012 | 425 | 0.070 |
Why?
| | Neuromuscular Diseases | 1 | 2011 | 142 | 0.070 |
Why?
| | Zona Pellucida Glycoproteins | 1 | 2008 | 2 | 0.070 |
Why?
| | Growth Differentiation Factor 9 | 1 | 2008 | 4 | 0.070 |
Why?
| | Communicable Diseases | 2 | 2022 | 161 | 0.070 |
Why?
| | Connexin 43 | 1 | 2008 | 35 | 0.070 |
Why?
| | Embryonic Development | 1 | 2008 | 118 | 0.070 |
Why?
| | Appointments and Schedules | 2 | 2019 | 96 | 0.070 |
Why?
| | Cell Phone | 2 | 2019 | 82 | 0.060 |
Why?
| | Tendons | 1 | 2008 | 123 | 0.060 |
Why?
| | Leukocytes | 1 | 2008 | 306 | 0.060 |
Why?
| | Ovary | 1 | 2008 | 225 | 0.060 |
Why?
| | Health Surveys | 2 | 2018 | 511 | 0.060 |
Why?
| | Mice, Inbred BALB C | 1 | 2008 | 1271 | 0.060 |
Why?
| | Sphenoid Sinus | 1 | 2025 | 11 | 0.060 |
Why?
| | Sphenoid Bone | 1 | 2025 | 15 | 0.060 |
Why?
| | Central Nervous System Cysts | 1 | 2025 | 13 | 0.060 |
Why?
| | Fetal Development | 1 | 2008 | 296 | 0.060 |
Why?
| | Tranexamic Acid | 1 | 2025 | 47 | 0.060 |
Why?
| | Antifibrinolytic Agents | 1 | 2025 | 57 | 0.060 |
Why?
| | Blood Loss, Surgical | 1 | 2025 | 112 | 0.060 |
Why?
| | Immobilization | 1 | 2004 | 46 | 0.050 |
Why?
| | Erythropoietin | 1 | 2025 | 98 | 0.050 |
Why?
| | Homeodomain Proteins | 1 | 2008 | 512 | 0.050 |
Why?
| | Tetracyclines | 1 | 2024 | 14 | 0.050 |
Why?
| | Technology Assessment, Biomedical | 1 | 2024 | 39 | 0.050 |
Why?
| | Smallpox Vaccine | 1 | 2024 | 24 | 0.050 |
Why?
| | Electrodes, Implanted | 1 | 2024 | 112 | 0.050 |
Why?
| | Quality-Adjusted Life Years | 1 | 2024 | 112 | 0.050 |
Why?
| | Shoulder Dislocation | 1 | 2004 | 53 | 0.050 |
Why?
| | Palivizumab | 1 | 2023 | 12 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2025 | 223 | 0.050 |
Why?
| | Ligaments | 1 | 2024 | 74 | 0.050 |
Why?
| | Acromion | 1 | 2003 | 8 | 0.050 |
Why?
| | National Health Programs | 1 | 2023 | 20 | 0.050 |
Why?
| | Prognosis | 2 | 2023 | 4060 | 0.050 |
Why?
| | Adenoma | 1 | 2025 | 216 | 0.050 |
Why?
| | Neoplasms | 1 | 2018 | 2718 | 0.050 |
Why?
| | Labor, Induced | 1 | 2022 | 36 | 0.050 |
Why?
| | Health Services | 1 | 2023 | 115 | 0.050 |
Why?
| | Technology | 1 | 2023 | 94 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 74 | 0.050 |
Why?
| | Term Birth | 1 | 2022 | 24 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 2 | 2025 | 2760 | 0.050 |
Why?
| | Joint Instability | 1 | 2024 | 168 | 0.050 |
Why?
| | Sheep | 1 | 2024 | 872 | 0.050 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2025 | 238 | 0.050 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2001 | 29 | 0.050 |
Why?
| | Hysteroscopy | 1 | 2021 | 13 | 0.040 |
Why?
| | Hand Strength | 1 | 2002 | 132 | 0.040 |
Why?
| | Tissue Adhesions | 1 | 2021 | 33 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2024 | 851 | 0.040 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2001 | 56 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2025 | 897 | 0.040 |
Why?
| | Psychiatric Nursing | 1 | 2001 | 11 | 0.040 |
Why?
| | Autonomic Nervous System | 1 | 2001 | 79 | 0.040 |
Why?
| | Dissociative Disorders | 1 | 2001 | 25 | 0.040 |
Why?
| | Multigene Family | 1 | 2001 | 202 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2025 | 1022 | 0.040 |
Why?
| | Cadaver | 2 | 2004 | 301 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2021 | 68 | 0.040 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2020 | 40 | 0.040 |
Why?
| | Equivalence Trials as Topic | 1 | 2020 | 33 | 0.040 |
Why?
| | Nurse-Patient Relations | 1 | 2001 | 67 | 0.040 |
Why?
| | Vaccines, Attenuated | 1 | 2021 | 130 | 0.040 |
Why?
| | Transcription Factors | 1 | 2008 | 1703 | 0.040 |
Why?
| | Hip Prosthesis | 1 | 2000 | 46 | 0.040 |
Why?
| | Lateral Ventricles | 1 | 2000 | 32 | 0.040 |
Why?
| | Inpatients | 1 | 2024 | 512 | 0.040 |
Why?
| | Cerebral Revascularization | 1 | 2019 | 22 | 0.040 |
Why?
| | Social Networking | 1 | 2020 | 35 | 0.040 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2020 | 126 | 0.040 |
Why?
| | Myocardial Ischemia | 1 | 2001 | 280 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2021 | 230 | 0.040 |
Why?
| | Catheterization | 1 | 2000 | 182 | 0.040 |
Why?
| | Maternal Age | 1 | 2019 | 128 | 0.040 |
Why?
| | Lower Extremity | 1 | 2023 | 436 | 0.040 |
Why?
| | Ultrasonography | 1 | 2003 | 760 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 362 | 0.040 |
Why?
| | Nursing Staff, Hospital | 1 | 2001 | 160 | 0.040 |
Why?
| | Knee Joint | 1 | 2022 | 412 | 0.040 |
Why?
| | Equipment Design | 1 | 2000 | 525 | 0.040 |
Why?
| | Patient Discharge | 1 | 2025 | 930 | 0.040 |
Why?
| | Pharmacists | 1 | 2021 | 255 | 0.040 |
Why?
| | Family | 1 | 2022 | 677 | 0.040 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2018 | 77 | 0.030 |
Why?
| | Crohn Disease | 1 | 2001 | 254 | 0.030 |
Why?
| | Awareness | 1 | 2018 | 102 | 0.030 |
Why?
| | Heart Rate | 1 | 2001 | 821 | 0.030 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2017 | 27 | 0.030 |
Why?
| | Educational Status | 1 | 2019 | 462 | 0.030 |
Why?
| | Accessory Nerve | 1 | 1997 | 4 | 0.030 |
Why?
| | Internationality | 1 | 2018 | 157 | 0.030 |
Why?
| | Risk Assessment | 3 | 2015 | 3484 | 0.030 |
Why?
| | Phenotype | 1 | 2025 | 3172 | 0.030 |
Why?
| | Patients | 1 | 2018 | 179 | 0.030 |
Why?
| | Health Plan Implementation | 1 | 2018 | 142 | 0.030 |
Why?
| | Mice | 2 | 2017 | 18057 | 0.030 |
Why?
| | Mental Disorders | 1 | 2025 | 1123 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2017 | 219 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2018 | 239 | 0.030 |
Why?
| | Genetic Variation | 1 | 2001 | 994 | 0.030 |
Why?
| | Nurse Practitioners | 1 | 2018 | 140 | 0.030 |
Why?
| | Self Report | 1 | 2020 | 858 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1313 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2018 | 453 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2019 | 580 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2019 | 690 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 353 | 0.030 |
Why?
| | Ergonomics | 1 | 2014 | 24 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2018 | 429 | 0.030 |
Why?
| | Prescriptions | 1 | 2014 | 73 | 0.030 |
Why?
| | Wound Infection | 1 | 2014 | 37 | 0.030 |
Why?
| | Occupational Injuries | 1 | 2014 | 44 | 0.030 |
Why?
| | Efficiency | 1 | 2014 | 101 | 0.030 |
Why?
| | Abscess | 1 | 2014 | 77 | 0.030 |
Why?
| | Blood Glucose | 1 | 2024 | 2273 | 0.030 |
Why?
| | Program Evaluation | 1 | 2018 | 919 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2051 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2920 | 0.030 |
Why?
| | Medically Uninsured | 1 | 2014 | 136 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2001 | 2368 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 191 | 0.020 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 13 | 0.020 |
Why?
| | Pharmaceutical Services | 1 | 2011 | 83 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1269 | 0.020 |
Why?
| | Biomechanical Phenomena | 2 | 2004 | 837 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2014 | 794 | 0.020 |
Why?
| | Exercise | 2 | 2014 | 2108 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2898 | 0.020 |
Why?
| | Rotation | 1 | 2004 | 121 | 0.010 |
Why?
| | Palliative Care | 1 | 2011 | 819 | 0.010 |
Why?
| | Posture | 1 | 2004 | 194 | 0.010 |
Why?
| | Range of Motion, Articular | 1 | 2004 | 413 | 0.010 |
Why?
| | Machiavellianism | 1 | 2001 | 1 | 0.010 |
Why?
| | Nursing Methodology Research | 1 | 2001 | 45 | 0.010 |
Why?
| | Helping Behavior | 1 | 2001 | 19 | 0.010 |
Why?
| | Linkage Disequilibrium | 1 | 2001 | 254 | 0.010 |
Why?
| | Chromium Alloys | 1 | 2000 | 5 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2001 | 504 | 0.010 |
Why?
| | Durapatite | 1 | 2000 | 36 | 0.010 |
Why?
| | Psychological Theory | 1 | 2001 | 95 | 0.010 |
Why?
| | Bone Cements | 1 | 2000 | 41 | 0.010 |
Why?
| | Porosity | 1 | 2000 | 100 | 0.010 |
Why?
| | Coated Materials, Biocompatible | 1 | 2000 | 65 | 0.010 |
Why?
| | Survival Analysis | 1 | 2000 | 1320 | 0.010 |
Why?
| | Social Support | 1 | 2001 | 629 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2001 | 2128 | 0.010 |
Why?
| | Stress, Psychological | 1 | 2001 | 1122 | 0.010 |
Why?
|
|
O'Leary's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|